iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by Choreo LLC

Choreo LLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 54.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,465 shares of the financial services provider’s stock after acquiring an additional 1,228 shares during the period. Choreo LLC’s holdings in iShares Biotechnology ETF were worth $475,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of IBB. Corient Private Wealth LLC lifted its position in iShares Biotechnology ETF by 1.0% in the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock valued at $11,778,000 after acquiring an additional 841 shares during the last quarter. Mmbg Investment Advisors CO. raised its holdings in shares of iShares Biotechnology ETF by 0.6% in the fourth quarter. Mmbg Investment Advisors CO. now owns 78,550 shares of the financial services provider’s stock valued at $10,671,000 after buying an additional 495 shares during the last quarter. Oppenheimer & Co. Inc. raised its holdings in shares of iShares Biotechnology ETF by 7.6% in the first quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock valued at $4,905,000 after buying an additional 2,532 shares during the last quarter. Chemistry Wealth Management LLC raised its holdings in shares of iShares Biotechnology ETF by 20.6% in the first quarter. Chemistry Wealth Management LLC now owns 3,560 shares of the financial services provider’s stock valued at $488,000 after buying an additional 609 shares during the last quarter. Finally, Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF in the first quarter valued at about $27,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.5 %

Shares of NASDAQ:IBB opened at $147.81 on Monday. The company has a 50-day simple moving average of $145.10 and a 200-day simple moving average of $138.27. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.17.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.